214 related articles for article (PubMed ID: 20199581)
1. French summaries of product characteristics: content in relation to therapeutic monitoring of psychotropic drugs.
Rougemont M; Ulrich S; Hiemke C; Corruble E; Baumann P
Fundam Clin Pharmacol; 2010 Jun; 24(3):377-84. PubMed ID: 20199581
[TBL] [Abstract][Full Text] [Related]
2. Value and actuality of the prescription information for therapeutic drug monitoring of psychopharmaceuticals: a comparison with the medico-scientific evidence.
Ulrich S; Hiemke C; Laux G; Müller-Oerlinghausen B; Havemann-Reinecke U; Riederer P; Zernig G; Baumann P;
Pharmacopsychiatry; 2007 May; 40(3):121-7. PubMed ID: 17541888
[TBL] [Abstract][Full Text] [Related]
3. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.
Baumann P; Hiemke C; Ulrich S; Eckermann G; Gaertner I; Gerlach M; Kuss HJ; Laux G; Müller-Oerlinghausen B; Rao ML; Riederer P; Zernig G;
Pharmacopsychiatry; 2004 Nov; 37(6):243-65. PubMed ID: 15551191
[TBL] [Abstract][Full Text] [Related]
4. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.
Hiemke C; Baumann P; Bergemann N; Conca A; Dietmaier O; Egberts K; Fric M; Gerlach M; Greiner C; Gründer G; Haen E; Havemann-Reinecke U; Jaquenoud Sirot E; Kirchherr H; Laux G; Lutz UC; Messer T; Müller MJ; Pfuhlmann B; Rambeck B; Riederer P; Schoppek B; Stingl J; Uhr M; Ulrich S; Waschgler R; Zernig G
Pharmacopsychiatry; 2011 Sep; 44(6):195-235. PubMed ID: 22053351
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic drug monitoring (TDM) of psychotropic drugs: a consensus guideline of the AGNP-TDM group].
Baumann P; Hiemke C; Ulrich S; Eckermann G; Kuss HL; Laux G; Müller-Oerlingenhausen B; Rao ML; Riederer P; Zernig G; ;
Rev Med Suisse; 2006 May; 2(67):1413-8, 1420-2, 1424-6. PubMed ID: 16786958
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic monitoring of psychotropic drugs: an outline of the AGNP-TDM expert group consensus guideline.
Baumann P; Hiemke C; Ulrich S; Gaertner I; Rao ML; Eckermann G; Gerlach M; Kuss HJ; Laux G; Müller-Oerlinghausen B; Riederer P; Zernig G
Ther Drug Monit; 2004 Apr; 26(2):167-70. PubMed ID: 15228159
[TBL] [Abstract][Full Text] [Related]
7. Consensus guideline for therapeutic drug monitoring in psychiatry (2004): Bibliometric analysis of citations for the period 2004-2011.
Schäfer A; Hiemke C; Baumann P
Nord J Psychiatry; 2016; 70(3):202-7. PubMed ID: 26399163
[TBL] [Abstract][Full Text] [Related]
8. A Critical Commentary on the 2017 AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology.
de Leon J
Pharmacopsychiatry; 2018 Jan; 51(1-02):63-68. PubMed ID: 28922669
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic drug monitoring of antidepressants--clinical aspects.
Laux G; Baumann P; Hiemke C;
J Neural Transm Suppl; 2007; (72):261-7. PubMed ID: 17982902
[TBL] [Abstract][Full Text] [Related]
10. AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011.
Hiemke C; Baumann P; Bergemann N; Conca A; Dietmaier O; Egberts K; Fric M; Gerlach M; Greiner C; Gründer G; Haen E; Havemann-Reinecke U; Jaquenoud Sirot E; Kirchherr H; Laux G; Lutz UC; Messer T; Müller MJ; Pfuhlmann B; Rambeck B; Riederer P; Schoppek B; Stingl J; Uhr M; Ulrich S; Waschgler R; Zernig G
Pharmacopsychiatry; 2011 Sep; 44(6):195-235. PubMed ID: 21969060
[TBL] [Abstract][Full Text] [Related]
11. Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.
Hiemke C; Bergemann N; Clement HW; Conca A; Deckert J; Domschke K; Eckermann G; Egberts K; Gerlach M; Greiner C; Gründer G; Haen E; Havemann-Reinecke U; Hefner G; Helmer R; Janssen G; Jaquenoud E; Laux G; Messer T; Mössner R; Müller MJ; Paulzen M; Pfuhlmann B; Riederer P; Saria A; Schoppek B; Schoretsanitis G; Schwarz M; Gracia MS; Stegmann B; Steimer W; Stingl JC; Uhr M; Ulrich S; Unterecker S; Waschgler R; Zernig G; Zurek G; Baumann P
Pharmacopsychiatry; 2018 Jan; 51(1-02):9-62. PubMed ID: 28910830
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring in neuropsychopharmacology: does it hold its promises?
Hiemke C
Eur Arch Psychiatry Clin Neurosci; 2008 Mar; 258 Suppl 1():21-7. PubMed ID: 18344046
[TBL] [Abstract][Full Text] [Related]
13. TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians.
Schoretsanitis G; Paulzen M; Unterecker S; Schwarz M; Conca A; Zernig G; Gründer G; Haen E; Baumann P; Bergemann N; Clement HW; Domschke K; Eckermann G; Egberts K; Gerlach M; Greiner C; Havemann-Reinecke U; Hefner G; Helmer R; Janssen G; Jaquenoud-Sirot E; Laux G; Messer T; Mössner R; Müller MJ; Pfuhlmann B; Riederer P; Saria A; Schoppek B; Silva Gracia M; Stegmann B; Steimer W; Stingl JC; Uhr M; Ulrich S; Waschgler R; Zurek G; Hiemke C
World J Biol Psychiatry; 2018 Apr; 19(3):162-174. PubMed ID: 29493375
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic drug monitoring in psychiatry. A brief summary of the new consensus paper by the task force on TDM of the AGNP].
Gründer G; Baumann P; Conca A; Zernig G; Hiemke C;
Nervenarzt; 2014 Jul; 85(7):847-55. PubMed ID: 24346428
[TBL] [Abstract][Full Text] [Related]
15. Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie.
Schoretsanitis G; Kane JM; Correll CU; Marder SR; Citrome L; Newcomer JW; Robinson DG; Goff DC; Kelly DL; Freudenreich O; Piacentino D; Paulzen M; Conca A; Zernig G; Haen E; Baumann P; Hiemke C; Gründer G; ; Pharmakopsychiatrie TTDMTFOTAFNU
J Clin Psychiatry; 2020 May; 81(3):. PubMed ID: 32433836
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring in Italian psychiatry.
Conca A; Schmidt E; Pastore M; Hiemke C; Duffy D; Giupponi G
Pharmacopsychiatry; 2011 Sep; 44(6):259-62. PubMed ID: 21959788
[TBL] [Abstract][Full Text] [Related]
17. Can We Rely on AGNP Therapeutic Targets Also For LAI Antipsychotics?
Baldelli S; Clementi E; Cattaneo D
Pharmacopsychiatry; 2018 Nov; 51(6):270-271. PubMed ID: 29179228
[TBL] [Abstract][Full Text] [Related]
18. Consensus Guideline Based Therapeutic Drug Monitoring (TDM) in Psychiatry and Neurology.
Hiemke C
Curr Drug Deliv; 2016; 13(3):353-61. PubMed ID: 26511090
[TBL] [Abstract][Full Text] [Related]
19. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
20. 15th AGNP-Symposium. Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie. Nuremberg, October 1987.
Pharmacopsychiatry; 1988 Nov; 21(6):263-466. PubMed ID: 3244745
[No Abstract] [Full Text] [Related]
[Next] [New Search]
